BISEGNA, MARIA LAURA
BISEGNA, MARIA LAURA
DIPARTIMENTO DI MEDICINA TRASLAZIONALE E DI PRECISIONE
CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP
2024 Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania
CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions
2022 Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Diagnostica di laboratorio e strumentale
2022 Chistolini, Antonio; Fava, Carmen; Saglio, Giuseppe; Giona, Fiorina; Pavan, Laura; Bisegna, MARIA LAURA
Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients
2022 Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M.
Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds
2023 Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation
2024 Lagana, Alessandro; Passucci, Mauro; Pepe, Sara; Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo
NG2 molecule expression in acute lymphoblastic leukemia B cells: a flow-cytometric marker for the rapid identification of KMT2A gene rearrangements
2024 Bisegna, Maria Laura; Peragine, Nadia; Elia, Loredana; Matarazzo, Mabel; Milani, Maria Laura; Intoppa, Stefania; Di Trani, Mariangela; Malfona, Francesco; Martelli, Maurizio; De Propris, Maria Stefania
Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors
2024 Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic
2022 Laganà, Alessandro; Ferri, Gianluca; Passucci, Mauro; Salvatori, Martina; Bisegna, MARIA LAURA; Paoletti, Francesca; Aji, Francesco; Breccia, Massimo; Antonio Brunetti, Gregorio; Morano, Salvatore Giacomo; Annechini, Giorgia; Carmosino, Ida; Martelli, Maurizio; Girmenia, Corrado
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia
2024 Costa, Alessandro; Gurnari, Carmelo; Scalzulli, Emilia; Cicconi, Laura; Guarnera, Luca; Carmosino, Ida; Cerretti, Raffaella; Bisegna, Maria Laura; Capria, Saveria; Minotti, Clara; Iori, Anna Paola; Torrieri, Lorenzo; Venditti, Adriano; Pulsoni, Alessandro; Martelli, Maurizio; Voso, Maria Teresa; Breccia, Massimo
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report
2024 Ligia, Silvio; Scalzulli, Emilia; Carmosino, Ida; Palumbo, Giovanna; Molinari, Maria Chiara; Poggiali, Rebecca; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo
RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort
2022 Scalzulli, Emilia; Ielo, Claudia; Luise, Cristina; Musiu, Paolo; Bisegna, Maria L; Carmosino, Ida; Assanto, Giovanni M; Martelli, Maurizio; Breccia, Massimo
Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia
2024 Costa, Alessandro; Abruzzese, Elisabetta; Latagliata, Roberto; Mulas, Olga; Carmosino, Ida; Scalzulli, Emilia; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Caocci, Giovanni; Breccia, Massimo
Trapianto di cellule staminali
2022 Giona, Fiorina; Bisegna, MARIA LAURA
Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety
2024 Lagana, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Carmosino, Ida; Ielo, Claudia; Costa, Alessandro; Torrieri, Lorenzo; Totaro, Matteo; Martelli, Maurizio; Breccia, Massimo
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis
2022 Bisegna, Maria Laura; Noccioli, Niccolò; Della Starza, Irene; Peragine, Nadia; Di Rocco, Alice; De Propris, Maria Stefania
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CD146 MOLECULE EXPRESSION IN B CELLS ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALLs): A FLOW- CYTOMETRIC MARKER FOR AN ACCURATE DIAGNOSTIC WORK-UP | 2024 | Laganà, Alessandro; Totaro, Matteo; Bisegna, Maria Laura; Elia, Loredana; Intoppa, Stefania; Beldinanzi, Marco; Matarazzo, Mabel; Di Trani, Mariangela; Costa, Alessandro; Maglione, Raffaele; Mandelli, Biancamaria; Chiaretti, Sabina; Martelli, Maurizio; De Propris, Maria Stefania | |
| CML Resistant to 2nd-Generation TKIs: Mechanisms, Next Steps, and New Directions | 2022 | Scalzulli, Emilia; Carmosino, Ida; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Diagnostica di laboratorio e strumentale | 2022 | Chistolini, Antonio; Fava, Carmen; Saglio, Giuseppe; Giona, Fiorina; Pavan, Laura; Bisegna, MARIA LAURA | |
| Emerging concepts for assessing and predicting treatment-free remission in chronic myeloid leukemia patients | 2022 | Breccia, M.; Scalzulli, E.; Pepe, S.; Colafigli, G.; Bisegna, M. L.; Capriata, M.; Martelli, M. | |
| Management of Chronic Myeloid Leukemia Patients in Later Lines: The Role of Ponatinib and New Compounds | 2023 | Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Neutrophil to lymphocyte ratio in myelofibrosis patients treated with ruxolitinib may predict prognosis and rate of discontinuation | 2024 | Lagana, Alessandro; Passucci, Mauro; Pepe, Sara; Scalzulli, Emilia; Carmosino, Ida; Costa, Alessandro; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Breccia, Massimo | |
| NG2 molecule expression in acute lymphoblastic leukemia B cells: a flow-cytometric marker for the rapid identification of KMT2A gene rearrangements | 2024 | Bisegna, Maria Laura; Peragine, Nadia; Elia, Loredana; Matarazzo, Mabel; Milani, Maria Laura; Intoppa, Stefania; Di Trani, Mariangela; Malfona, Francesco; Martelli, Maurizio; De Propris, Maria Stefania | |
| Pharmacotherapeutic advances for chronic myelogenous leukemia: beyond tyrosine kinase inhibitors | 2024 | Costa, Alessandro; Scalzulli, Emilia; Carmosino, Ida; Ielo, Claudia; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic | 2022 | Laganà, Alessandro; Ferri, Gianluca; Passucci, Mauro; Salvatori, Martina; Bisegna, MARIA LAURA; Paoletti, Francesca; Aji, Francesco; Breccia, Massimo; Antonio Brunetti, Gregorio; Morano, Salvatore Giacomo; Annechini, Giorgia; Carmosino, Ida; Martelli, Maurizio; Girmenia, Corrado | |
| Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia | 2024 | Costa, Alessandro; Gurnari, Carmelo; Scalzulli, Emilia; Cicconi, Laura; Guarnera, Luca; Carmosino, Ida; Cerretti, Raffaella; Bisegna, Maria Laura; Capria, Saveria; Minotti, Clara; Iori, Anna Paola; Torrieri, Lorenzo; Venditti, Adriano; Pulsoni, Alessandro; Martelli, Maurizio; Voso, Maria Teresa; Breccia, Massimo | |
| Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report | 2024 | Ligia, Silvio; Scalzulli, Emilia; Carmosino, Ida; Palumbo, Giovanna; Molinari, Maria Chiara; Poggiali, Rebecca; Costa, Alessandro; Bisegna, Maria Laura; Martelli, Maurizio; Breccia, Massimo | |
| RR6 prognostic model provides information about survival for myelofibrosis treated with ruxolitinib: validation in a real-life cohort | 2022 | Scalzulli, Emilia; Ielo, Claudia; Luise, Cristina; Musiu, Paolo; Bisegna, Maria L; Carmosino, Ida; Assanto, Giovanni M; Martelli, Maurizio; Breccia, Massimo | |
| Safety and Efficacy of TKIs in very Elderly Patients (≥75 Years) with Chronic Myeloid Leukemia | 2024 | Costa, Alessandro; Abruzzese, Elisabetta; Latagliata, Roberto; Mulas, Olga; Carmosino, Ida; Scalzulli, Emilia; Bisegna, Maria Laura; Ielo, Claudia; Martelli, Maurizio; Caocci, Giovanni; Breccia, Massimo | |
| Trapianto di cellule staminali | 2022 | Giona, Fiorina; Bisegna, MARIA LAURA | |
| Treatment free remission (TFR) after second-generation tyrosine kinase inhibitors (2G-TKIs) treatment in chronic myeloid leukemia (CML): from feasibility to safety | 2024 | Lagana, Alessandro; Scalzulli, Emilia; Bisegna, Maria Laura; Carmosino, Ida; Ielo, Claudia; Costa, Alessandro; Torrieri, Lorenzo; Totaro, Matteo; Martelli, Maurizio; Breccia, Massimo | |
| Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis | 2022 | Bisegna, Maria Laura; Noccioli, Niccolò; Della Starza, Irene; Peragine, Nadia; Di Rocco, Alice; De Propris, Maria Stefania |